Abstract
No translate
No translate
References
1.
Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-144. doi:10.1177/17474930241308142\
2.
Tran MC, Prisco L, Pham PM, et al. Comprehensive analysis of stroke epidemiology in Vietnam: insights from GBD 1990-2019 and RES-Q 2017-2023. Glob Epidemiol. 2025;9:100199. doi:10.1016/j.gloepi.2025.100199\
3.
Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I-LXII. doi:10.1177/2396987321989865\
4.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211\
5.
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-1329. doi:10.1056/NEJMoa0804656\
6.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587. doi:10.1056/NEJM199512143332401\
7.
Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378(17):1573-1582. doi:10.1056/NEJMoa1716405\
8.
Menon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400(10347):161-169. doi:10.1016/S0140-6736(22)01054-6\
9.
Mori M, Naganuma M, Okada Y, et al. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis. 2012;34(2):140-146. doi:10.1159/000339759\
10.
Kharitonova T, Mikulik R, Roine RO, et al. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke. 2011;42(6):1638-1643. doi:10.1161/STROKEAHA.110.606194\
11.
Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke. 2004;35(1):147-150.\
12.
Yeo LLL, Paliwal P, Teoh HL, et al. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(8):e590-e596. doi:10.1016/j.jstrokecerebrovasdis.2013.07.024\
13.
Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866-874. doi:10.1016/S1474-4422(10)70165-4\
14.
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064-2089. doi:10.1161/STR.0b013e318296aeca\
15.
Xiufu Z, Ruipeng L, Jun Z, et al. Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke. Front Neurol. 2022;13:1037663. doi:10.3389/fneur.2022.1037663\
16.
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935. doi:10.1016/S0140-6736(14)60584-5\
17.
Kalmar PJ, Tarkanyi G, Karadi ZN, Szapary L, Bosnyak E. The impact of diabetes mellitus and admission hyperglycemia on clinical outcomes after recanalization therapies for acute ischemic stroke: STAY ALIVE National Prospective Registry. Life (Basel). 2022;12(5):632. doi:10.3390/life12050632\
18.
Kruyt ND, Biessels GJ, DeVries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145-155. doi:10.1038/nrneurol.2009.231
Authors
Files
Trích dẫn
Article Views7
Document Views3
Downloads1
Section
Articles
Issue
Số 51 - 2026
Category
Đột quỵ
Pages
17-25
Copyright Holder
2026 Tạp chí thần kinh học Việt Nam